FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fentanyl Citrate (Sublimaze) Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Analgesia/Addiction; Pediatric

Expand all

Akorn Pharmaceuticals (Revised 12/02/2019)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2 mL ampule 10 pack (NDC 17478-0030-02) Available Other
2 mL ampule; 25 pack (NDC 17478-0030-25) Available Other
5 mL ampule 10 pack (NDC 17478-0030-05) Available Other
20 mL ampule (NDC 17478-0030-20) Available Other
5 mL ampule 25 pack (NDC 17478-0030-55) Available Other

Fresenius Kabi USA, LLC (Reverified 11/16/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1,000 mcg per 20 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-20) Available Check wholesalers for inventory. Increase in demand
2,500 mcg per 50 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-50) Available Check wholesalers for inventory. Increase in demand
50 mcg per 1 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-01) Available Check wholesalers for inventory. Increase in demand
100 mcg per 2 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-02) Available Check wholesalers for inventory. Increase in demand
250 mcg per 5 mL (50 mcg per mL) (0.05 mg per mL) SDV (NDC 63323-806-05) Available Check wholesalers for inventory. Increase in demand

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 07/22/2020)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mcg/mL 2 mL ampul (NDC 0641-6024-10) Currently not available Inventory available in vial presentations. Demand increase for the drug
50 mcg/mL 5 mL ampul (NDC 0641-6025-10) Currently not available Inventory available in vial presentations. Demand increase for the drug
50 mcg/mL 20 mL ampul (NDC 0641-6026-05) Currently not available Inventory available in vial presentations. Demand increase for the drug
50 mcg/mL 2 mL vial (NDC 0641-6027-25) Inventory is currently available. Additional lots are scheduled for manufacturing in the July - August 2020 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 5 mL vial (NDC 0641-6028-25) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing in the July - August 2020 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 20 mL vial (NDC 0641-6029-25) This presentation is temporarily on backorder. Additional lots are scheduled for manufacturing in the July - August 2020 timeframe. Product will be made available as it is released. Demand increase for the drug
50 mcg/mL 50 mL vial (NDC 0641-6030-01) This presentation is temporarily on backorder. Additional lots will be scheduled for manufacturing in the July - August 2020 timeframe. Product will be made available as it is released. Demand increase for the drug

Hospira, Inc. (Revised 11/20/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mcg/2 mL (50 mcg/mL); Carpuject Luer Lock Glass Syringe (NDC 00409-1276-32) Next Delivery and Estimated Recovery: January 2023

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Demand increase for the drug
100 mcg/2 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-32) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
250 mcg/5 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-35) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
1000 mcg/20 mL (50 mcg/mL); Glass Ampul (NDC 00409-9093-38) Discontinued

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Discontinuation of the manufacture of the drug
100 mcg/2 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-22) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

250 mcg/5 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-25) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
500 mcg/10 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-28) Available

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
1,000 mcg/20 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-31) Limited Supply Available.

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Other
2,500 mcg/50 mL (50 mcg/mL); Single Dose Glass Fliptop Vial (NDC 00409-9094-61) Limited Supply Available. Next Delivery: November 2020; Estimated Recovery: February 2021

Dear Customer Letter - Supply Update of Earlier Delivery Dates

Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English